|
Downstream of Akt in the tumor vessel
|
1R01CA131152-01A1
|
$446,580
|
$446,580
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-18
|
$1,680,173
|
$336,035
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
5R01CA097193-07
|
$1,563,010
|
$312,602
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Metalloproteinases in Tumor Neovascularization
|
5R01CA083017-10
|
$285,237
|
$285,237
|
STRONGIN, ALEX
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-28
|
$3,649,220
|
$72,984
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Attenuation of Radiation-Induced GI Injury by Cultured Myeloid Progenitors
|
5R41CA126604-02
|
$294,835
|
$147,418
|
Christensen, Julie
|
CELLERANT THERAPEUTICS, INC.
|
|
Regulation of Angiogenesis
|
5P01CA045548-22
|
$1,598,578
|
$1,598,578
|
INGBER, DONALD
|
CHILDREN'S HOSPITAL BOSTON
|
|
Growth Genes, Extracellular Matrix and Angiogenesis
|
5R01CA055833-15
|
$311,052
|
$311,052
|
INGBER, DONALD
|
CHILDREN'S HOSPITAL BOSTON
|
|
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR
|
5R37CA037392-27
|
$683,003
|
$478,102
|
KLAGSBRUN, MICHAEL
|
CHILDREN'S HOSPITAL BOSTON
|
|
Photodynamic Therapy Affects on the Tumor Microenvironment
|
5R01CA031230-24
|
$336,685
|
$168,343
|
GOMER, CHARLES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Inhibition of VEGF Mediated Angiogenesis by TIMP-3
|
5R01CA106415-04
|
$265,216
|
$265,216
|
ANAND-APTE, BELA
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
ANALYSIS OF Id GENE TARGETS IN TUMOR ENDOTHELIAL CELLS
|
5R01CA100933-05
|
$296,523
|
$296,523
|
MITTAL, VIVEK
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
5P30CA045508-22
|
$4,126,879
|
$165,075
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$2,868
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$232,835
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
The role of FOXO transcriptional factors in TSC-mediated tumorigenesis
|
1R21CA135057-01
|
$171,000
|
$171,000
|
DePinho, Ronald
|
DANA-FARBER CANCER INSTITUTE
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
3R01CA105255-05S1
|
$53,605
|
$53,605
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
ALK-1 and Endoglin Signaling in Endothelial Cells
|
5R01CA105255-05
|
$265,114
|
$265,114
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
Heat And Radiation Effects On Tumor Microcirulation
|
5R01CA040355-24
|
$305,504
|
$305,504
|
DEWHIRST, MARK
|
DUKE UNIVERSITY
|
|
Novel Roles for beta-arrestin2 in TGF-beta mediated Endoglin Signaling
|
1F32CA124139-01A2
|
$49,646
|
$49,646
|
LEE, NAM
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S1
|
$40,000
|
$800
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S2
|
|
$0
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S3
|
$249,999
|
$5,000
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S4
|
$85,106
|
$1,702
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S5
|
$100,000
|
$2,000
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-34
|
$6,558,287
|
$131,166
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-10S1
|
$125,023
|
$1,250
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-10S2
|
$193,710
|
$1,937
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-10
|
$2,780,246
|
$27,802
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Growth Factor as Anti-angiogenesis Agents
|
5R01CA106829-05
|
$326,968
|
$326,968
|
SEBTI, SAID
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Cryptic Domains of Collagen-IV in Tumor Growth
|
5R01CA091645-07
|
$335,687
|
$167,844
|
BROOKS, PETER
|
MAINE MEDICAL CENTER
|
|
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
|
2R01CA096915-06A1
|
$309,082
|
$309,082
|
FUKUMURA, DAI
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
Z01 CP010183-00560
|
$4,450
|
$222
|
Anderson, William
|
DCEG (NCI)
|
|
Molecular Mechanism of Action of Phorbol Ester
|
Z01 BC 005270
|
$1,471,861
|
$147,186
|
Blumberg, Peter
|
CCR (NCI)
|
|
The Role of JAM-C in Adhesive Interactions of Immune Cells
|
Z01 BC 010663
|
$223,073
|
$66,922
|
Chavakis, Triantafyllos
|
CCR (NCI)
|
|
Crosstalk Between Inflammation and Angiogenesis
|
Z01 BC 010664
|
$223,073
|
$55,768
|
Chavakis, Triantafyllos
|
CCR (NCI)
|
|
Regulation of Leukocyte Integrins in Inflammatory Cell Recruitment
|
Z01 BC 010790
|
$297,431
|
$118,973
|
Chavakis, Triantafyllos
|
CCR (NCI)
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
Z01 BC 005673
|
$1,225,024
|
$980,019
|
Keefer, Larry
|
CCR (NCI)
|
|
Studies of Proteins with Important Roles in Immunology and/or Cancer Biology
|
Z01 BC 010761
|
$192,535
|
$19,254
|
Lubkowski, Jacek
|
CCR (NCI)
|
|
Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages
|
Z01 BC 010300
|
$468,491
|
$93,698
|
McVicar, Daniel
|
CCR (NCI)
|
|
Metabolic Mechanisms for Programmed Cell Death
|
Z01 BC 010743
|
$497,681
|
$74,652
|
Phang, James
|
CCR (NCI)
|
|
Cellular Interactions with Thrombospondin
|
Z01 SC 009172
|
$540,174
|
$432,139
|
Roberts, David
|
CCR (NCI)
|
|
TEM5 Ligand Hunt
|
Z01 BC 010483
|
$172,500
|
$138,001
|
St. Croix, Brad
|
CCR (NCI)
|
|
Functional Analysis of TEM5 and TEM8
|
Z01 BC 010484
|
$172,500
|
$69,000
|
St. Croix, Brad
|
CCR (NCI)
|
|
Search for New Tumor Endothelial Markers
|
Z01 BC 010486
|
$172,500
|
$86,250
|
St. Croix, Brad
|
CCR (NCI)
|
|
Targeting TEMs in Preclinical Tumor Models
|
Z01 BC 010578
|
$172,500
|
$103,500
|
St. Croix, Brad
|
CCR (NCI)
|
Total relevant funding to Vascular Disease for this search: $19,048,470
|